Parkside Financial Bank & Trust Incyte Corp Transaction History

Parkside Financial Bank & Trust

$702 Million
Q3 2024

A detailed history of Parkside Financial Bank & Trust transactions in Incyte Corp stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 367 shares of INCY stock, worth $25,528. This represents 0.0% of its overall portfolio holdings.

Number of Shares

367

Previous 364 0.82%

Holding current value

$25,528

Previous $22,000 9.09%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$57.33 - $68.61 $171 - $205	3 Added 0.82%	367 $24,000
Q2 2024 Aug 05, 2024	BUY	$51.18 - $63.75 $4,708 - $5,865	92 Added 33.82%	364 $22,000
Q4 2023 Feb 01, 2024	SELL	$52.16 - $64.19 $4,120 - $5,071	-79 Reduced 22.51%	272 $17,000
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $3,581 - $4,087	62 Added 21.45%	351 $20,000
Q2 2023 Aug 15, 2023	SELL	$60.95 - $75.51 $2,194 - $2,718	-36 Reduced 11.08%	289 $17,000
Q1 2023 May 04, 2023	BUY	$70.23 - $86.01 $2,177 - $2,666	31 Added 10.54%	325 $23,000
Q4 2022 Feb 13, 2023	SELL	$67.18 - $84.11 $3,157 - $3,953	-47 Reduced 13.78%	294 $23,000
Q3 2022 Nov 01, 2022	SELL	$66.18 - $82.86 $6,220 - $7,788	-94 Reduced 21.61%	341 $23,000
Q2 2022 Jul 13, 2022	SELL	$66.18 - $83.18 $794 - $998	-12 Reduced 2.68%	435 $33,000
Q1 2022 May 13, 2022	BUY	$66.02 - $79.71 $14,062 - $16,978	213 Added 91.03%	447 $36,000
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $3,800 - $4,446	60 Added 34.48%	234 $17,000
Q3 2021 Oct 29, 2021	BUY	$68.67 - $84.02 $3,433 - $4,201	50 Added 40.32%	174 $12,000
Q2 2021 Aug 06, 2021	BUY	$79.87 - $87.53 $638 - $700	8 Added 6.9%	124 $10,000
Q1 2021 May 10, 2021	SELL	$76.02 - $100.5 $228 - $301	-3 Reduced 2.52%	116 $9,000
Q4 2020 Feb 09, 2021	SELL	$80.74 - $97.7 $242 - $293	-3 Reduced 2.46%	119 $10,000
Q3 2020 Nov 06, 2020	SELL	$85.07 - $109.69 $1,361 - $1,755	-16 Reduced 11.59%	122 $11,000
Q2 2020 Aug 10, 2020	SELL	$74.18 - $108.93 $370 - $544	-5 Reduced 3.5%	138 $14,000
Q1 2020 May 05, 2020	SELL	$63.18 - $85.97 $2,527 - $3,438	-40 Reduced 21.86%	143 $10,000
Q4 2019 Jan 30, 2020	BUY	$73.04 - $95.72 $949 - $1,244	13 Added 7.65%	183 $16,000
Q3 2019 Nov 05, 2019	SELL	$72.82 - $86.52 $8,956 - $10,641	-123 Reduced 41.98%	170 $13,000
Q2 2019 Aug 06, 2019	BUY	$73.52 - $88.7 $735 - $887	10 Added 3.53%	293 $25,000
Q1 2019 May 01, 2019	BUY	$63.56 - $88.17 $7,817 - $10,844	123 Added 76.88%	283 $24,000
Q4 2018 Jan 31, 2019	BUY	$58.5 - $69.94 $1,638 - $1,958	28 Added 21.21%	160 $10,000
Q3 2018 Oct 12, 2018	BUY	$61.75 - $74.23 $1,049 - $1,261	17 Added 14.78%	132 $9,000
Q2 2018 Aug 03, 2018	BUY	$60.85 - $83.98 $3,164 - $4,366	52 Added 82.54%	115 $8,000
Q1 2018 May 02, 2018	BUY	$83.06 - $100.98 $2,325 - $2,827	28 Added 80.0%	63 $5,000
Q4 2017 Feb 05, 2018	SELL	$93.56 - $116.6 $14,501 - $18,073	-155 Reduced 81.58%	35 $3,000
Q3 2017 Oct 27, 2017	BUY	$109.15 - $138.27 $20,738 - $26,271	190	190 $22,000

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.

Account

Parkside Financial Bank & Trust Incyte Corp Transaction History